Clinical trial
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
NCT00458887 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00458887 |
|---|---|
| Title | Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin |
| Official title | A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Procedure |
| Interventions | management of therapy complications |
| Enrollment | 301 |
| Start date | May 1, 2007 |
| Primary completion | Jan 1, 2015 |
| Completion | Feb 28, 2017 |
| First posted | Apr 11, 2007 |
| Last update posted | Mar 13, 2017 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: